Health News Archive - June 22, 2010
The nature-nurture debate is usually about how much of something is due to our genes and how much is caused by our environment.
Surveillance colonoscopy is effective and cost-effective when targeted to high-risk patients.
A large, academic medical center implemented an imaging algorithm that allowed radiologists to successfully reduce the cumulative radiation exposure and number of computed tomography (CT) angiography (CTA) and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages (a form of stroke).
A newly adapted low-dose computed tomography (CT) technique called adaptive statistical iterative reconstruction (ASIR) can help radiologists reduce the already low radiation dose delivered during CT colonography (CTC) by another 50 percent.
Standard radiography (X-rays) can help physicians diagnose laparoscopic adjustable gastric band slippage, a known complication of adjustable gastric banding surgery.
The APC protein serves as the colon's guardian, keeping tumors at bay.
A study published today in the journal Addiction reveals that drunkenness increases the risk for violent behaviour, but only for individuals with a strong inclination to suppress anger.
Pulmonary arterial hypertension (PAH) is a progressive disease, marked by shortness of breath and fatigue which can be fatal if untreated.
BEIJING, June 22 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will add two new centers to its extensive network by furthering its partnership with the PLA Navy General Hospital ("Navy General Hospital" or "the hospital"), located in Beijing. Concord Medical will add two new centers to the Beijing-based Navy General Hospital's existing facilities, bringing the total number of centers under the Company's management at the hospital to seven.
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of ProtandimÂ®, a patented, science-based solution to oxidative stress, announced today that a peer-reviewed manuscript was published in the Journal of Dietary Supplements examining the beneficial effects of ProtandimÂ® on a mouse model of Duchenne Muscular Dystrophy (DMD), an X-linked inherited disease affecting one in 3,500 males.